An exceptional safety profile has been shown in a large number of cell therapy clinical trials
that use mesenchymal stromal cells (MSCs). However, reliable potency assays are still …

Cell therapy with mesenchymal stromal cells (MSCs) is the focus of intensive investigation.
Several clinical trials, including large-scale placebo-controlled phase III clinical trials, are …

Mesenchymal stromal cells (MSC) have emerged as promising cell therapies for multiple
conditions based on demonstrations of their potent immunomodulatory and regenerative …

Mesenchymal stromal cells (MSCs) are being employed in clinical trials to facilitate
engraftment and to treat steroid‐resistant acute graft‐versus‐host disease after …

Graft versus host disease (GvHD) is a life-threating complication of allogeneic hematopoietic
stem cell transplantation, which is initially treated with high dose corticosteroids …

Mesenchymal stromal cells (MSC) are a population of phenotypically heterogeneous cells
that can be isolated from many readily accessible tissues, including bone marrow, umbilical …

Background Mesenchymal stromal cells (MSC) are largely investigated in clinical trials
aiming to control inappropriate immune reactions (GVHD, Crohn's disease, solid organ …

Graft versus host disease (GvHD) is the clinical condition in which bone marrow-derived
mesenchymal stromal cells (MSCs) have been most frequently studied. In this review, we …

Mesenchymal stromal/stem cells (MSCs) possess immunomodulatory and reparative
properties. Through specific interactions with immune cells that participate in both innate …

Mesenchymal stromal (stem) cells (MSCs) continue to be a strong area of focus for
academic-and industry-based researchers who share the goal of expanding their …